1
|
Osuagwu UL, Mashige KP, Ovenseri-Ogbomo G, Envuladu EA, Abu EK, Miner CA, Timothy CG, Ekpenyong BN, Langsi R, Amiebenomo OM, Oloruntoba R, Goson PC, Charwe DD, Ishaya T, Agho KE. The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa. BMC Public Health 2023; 23:38. [PMID: 36609264 PMCID: PMC9816548 DOI: 10.1186/s12889-022-14972-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Accepted: 12/29/2022] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND Vaccination remains the most powerful weapon against the emergence of new variants of coronavirus (COVID-19). However, false information about COVID-19 vaccines through various platforms including social media remains a major threat to global public health. This study examined the impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa (SSA). METHODS A validated web-based cross-sectional study was conducted from 14 March to 16 May 2021, and was administered in both French and English to 2572 participants aged 18 years and over. Data on sociodemographic characteristics, medical and vaccination history, and the information sources (mainstream media and social media) used by the participants during the pandemic were obtained. There were three main outcomes: The vaccinated group were those who responded in the affirmation (Yes) to the question of whether they have been vaccinated against COVID-19. Those who responded 'not sure' or 'no' to the question were then asked if they were willing to be vaccinated when the vaccine became available in their home countries. The responses to this follow-up question were used to derive the second and third outcome variables of 'vaccine hesitancy' and 'vaccine resistance', respectively. A series of logistic regression analyses were used to examine the impact of information sources on the three main outcomes. RESULTS The prevalence of COVID-19 vaccine hesitancy among the participants was lowest among newspaper readers (42%) and highest among TV (72%) and social media users (73%). The prevalence of COVID-19 vaccine-resistance was also lowest among newspaper readers (37%) but highest among social media users (87%). Multivariate analyses revealed that compared to those who did not use these information sources, SSA participants who relied on the radio (aOR 0.83, 95%CI = 0.70, 0.99), TV (aOR 0.80, 95%CI = 0.65, 0.97) and social media (aOR 0.79, 95%CI = 0.65, 0.97) for information during the pandemic were less likely to be hesitant towards taking the vaccines. However, social media users (aOR 2.13, 95%CI = 1.62, 2.80), those who watched TV (aOR 1.40, 95%CI =1.08, 1.80), relied on healthcare workers (HCWs: aOR 1.32, 95%CI = 1.07, 1.63) and families/friends (aOR 1.31, 95%CI = 1.06, 1.61) for COVID-19 related information during the pandemic were more likely to resist taking the COVID vaccines in this study. Participants who relied on the newspaper for information during the pandemic were less likely to resist the vaccines (aOR 0.77, 95%CI = 0.62, 0.95) compared to non-readers of a newspaper. CONCLUSION We found that all six information sources except radio were strong predictors of the resistance towards COVID-19 vaccination. Further research on how these channels can be used to improve the availability of reliable healthcare information is needed. Investments in these resources will protect people and empower them to make appropriate choices about their health.
Collapse
Affiliation(s)
- Uchechukwu L. Osuagwu
- grid.1029.a0000 0000 9939 5719Bathurst Rural Clinical School (BRCS), School of Medicine, Western Sydney University Bathurst, Bathurst, NSW 2795 Australia ,grid.16463.360000 0001 0723 4123African Vision Research Institute, Discipline of Optometry, Westville Campus, University of KwaZulu-Natal, Durban, 3629 South Africa ,grid.1029.a0000 0000 9939 5719Translational Health Research Institute (THRI), Western Sydney University, Campbeltown, NSW 2560 Australia
| | - Khathutshelo P. Mashige
- grid.16463.360000 0001 0723 4123African Vision Research Institute, Discipline of Optometry, Westville Campus, University of KwaZulu-Natal, Durban, 3629 South Africa
| | - Godwin Ovenseri-Ogbomo
- grid.23378.3d0000 0001 2189 1357Department of Optometry, University of the Highlands and Islands, Inverness, IV2 3JH UK
| | - Esther Awazzi Envuladu
- grid.412989.f0000 0000 8510 4538Department of Community Medicine, College of Health Sciences, University of Jos, Jos, 930003 Nigeria
| | - Emmanuel Kwasi Abu
- grid.413081.f0000 0001 2322 8567Department of Optometry and Vision Science, School of Allied Health Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, 00233 Ghana
| | - Chundung Asabe Miner
- grid.412989.f0000 0000 8510 4538Department of Community Medicine, College of Health Sciences, University of Jos, Jos, 930003 Nigeria
| | - Chikasirimobi G. Timothy
- grid.442592.c0000 0001 0746 093XDepartment of Optometry, Faculty of Health sciences, Mzuzu University, P. Bag 201 Luwinga 2,, Mzuzu, Malawi
| | - Bernadine N. Ekpenyong
- grid.16463.360000 0001 0723 4123African Vision Research Institute, Discipline of Optometry, Westville Campus, University of KwaZulu-Natal, Durban, 3629 South Africa ,grid.413097.80000 0001 0291 6387Department of Public Health, Faculty of Allied Medical Sciences, College of Medical Sciences, University of Calabar, Cross River State, Calabar, 540271 Nigeria
| | - Raymond Langsi
- grid.449799.e0000 0004 4684 0857Health Division, University of Bamenda, Bambili, P. O. Box 39, Cameroon
| | - Onyekachukwu M. Amiebenomo
- grid.413068.80000 0001 2218 219XDepartment of Optometry, Faculty of Life Sciences, University of Benin, Benin, Nigeria ,School of Optometry and Vision Sciences, College of Biomedical Sciences, Cardiff, CF24 4HQ UK
| | - Richard Oloruntoba
- grid.1032.00000 0004 0375 4078School of Management and Marketing, Curtin Business School, Curtin University, Bentley, WA 6151 Australia
| | - Piwuna Christopher Goson
- grid.412989.f0000 0000 8510 4538Department of Psychiatry, College of Health Sciences, University of Jos, Jos, Nigeria
| | - Deborah Donald Charwe
- grid.419861.30000 0001 2217 1343Tanzania Food and Nutrition Center, P. O. Box 977, Dar es Salaam, Tanzania
| | - Tanko Ishaya
- grid.412989.f0000 0000 8510 4538Department of Computer Science, University of Jos, Jos, 930003 Nigeria
| | - Kingsley E. Agho
- grid.16463.360000 0001 0723 4123African Vision Research Institute, Discipline of Optometry, Westville Campus, University of KwaZulu-Natal, Durban, 3629 South Africa ,grid.1029.a0000 0000 9939 5719Translational Health Research Institute (THRI), Western Sydney University, Campbeltown, NSW 2560 Australia ,grid.1029.a0000 0000 9939 5719School of Health Sciences, Western Sydney University, Campbelltown, NSW 2560 Australia
| |
Collapse
|
2
|
Schultz É, Atlani-Duault L, Peretti-Watel P, Ward JK. Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021. Therapie 2022; 77:591-602. [PMID: 35101281 PMCID: PMC8801974 DOI: 10.1016/j.therap.2022.01.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Revised: 12/29/2021] [Accepted: 01/10/2022] [Indexed: 11/24/2022]
Abstract
Objectives In the early stages of the coronavirus disease 2019 (COVID-19) pandemic, chloroquine and its derivatives such as hydroxychloroquine (HCQ) were widely commented upon both within the scientific community and in the media. This paper explores the different factors that influenced public perceptions in France of the efficacy of HCQ as well as their evolution between April 2020 and June 2021. Methods This article draws on 5 surveys conducted among representative samples of the French population (projects COCONEL and TRACTRUST; quota method, n = 1006; 1004; 2006; 1014 and 1005). We asked questions on the effectiveness of chloroquine against COVID-19. We also collected sociodemographic variables and attitudes toward politics and science. Results Between April and June 2021, the proportion of respondents who believed in the efficacy of HCQ decreased rapidly from 35% to 14%. The proportion of respondents who believed that HCQ is ineffective rose gradually from 6% to 21%. After adjusting for the temporal effect, the logistic regression showed a very strong association between political orientation and the belief in the efficacy of HCQ. Respondents who felt closest to the more radical parties (far-right and far-left) were more likely to believe in the efficacy of HCQ than those who felt closest to the political center (O.R. 2.48 [1.95–3.15] and 1.87 [1.44–2.43]). The role of trust in the government and in science and of the degree of political engagement were investigated in the two waves conducted after the scientific consensus was established during the summer of 2020. High levels of trust in the government and in science and of politicization are associated with belief of HCQ proven inefficacy. Across the whole period, a majority of respondents were uncertain. Even in 2021, 41.5% stated that the data were insufficient to decide whether or not HCQ is effective and 25.2% stating that they did not know. Conclusion Because media coverage of scientific controversies is higher in times of uncertainty than after these controversies have died down, the publicization of therapeutic promises can have lasting consequences on attitudes towards science and medicine.
Collapse
Affiliation(s)
- Émilien Schultz
- Université de Paris, IRD, Inserm, CEPED (UMR 196), 75006 Paris, France; Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Equipe CANBIOS Labellisée Ligue Contre le Cancer, 13005 Marseille, France.
| | - Laëtitia Atlani-Duault
- Université de Paris, IRD, Inserm, CEPED (UMR 196), 75006 Paris, France; Institut COVID-19 Add Memoriam, université de Paris, 75006 Paris, France; WHO Collaborative Center for Research on Health and Humanitarian Policies and Practices, IRD, université de Paris, 75006 Paris, France; Columbia University, Mailman School of Public Health, New York, NY, USA
| | - Patrick Peretti-Watel
- VITROME, Aix-Marseille université, IRD, AP-HM, SSA, 13005 Marseille, France; Observatoire régional de la santé PACA (ORS Paca), Aix-Marseille université, 13385 Marseille, France
| | - Jeremy K Ward
- VITROME, Aix-Marseille université, IRD, AP-HM, SSA, 13005 Marseille, France; CERMES3, Inserm, CNRS, EHESS, université de Paris, 94801 Villejuif, France
| |
Collapse
|